リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Evaluations of Gastric Acid Pocket Using Novel Vertical 8-channel pH Monitoring System and Effects of Acid Secretion Inhibitors」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Evaluations of Gastric Acid Pocket Using Novel Vertical 8-channel pH Monitoring System and Effects of Acid Secretion Inhibitors

角 昇平 島根大学

2021.06.02

概要

INTRODUCTION
Gastroesophageal reflux disease (GERD) is characterized by the presence of reflux symptoms, such as heartburn and regurgitation, and/or esophageal mucosal injury caused by reflux of gastric contents into the esophagus. Although the majority of gastroesophageal reflux episodes occur during the postprandial period, that finding is paradoxical, because intragastric acidity is reduced during that period by the buffering effects of food. In 2001, Fletcher et al. were the first to report the presence of an unbuffered acidic region in the proximal stomach during the postprandial period. This acid layer on top of an ingested meal, which escapes any buffering effects and is referred to as a gastric acid pocket, is now considered to be an important mechanism of GERD. However, details regarding acid pocket formation in GERD patients as well as healthy adults in Japan remain to be hlly elucidated. In addition, no known report regarding the effects of vonoprazan, a new potassium-competitive acid blocker, on acid pockets have been presented. To address these issues, we developed a novel catheter equipped with 8 vertically arrayed pH sensors. T he aim of this study was to evaluate gastric acid pockets formed in healthy Japanese subjects during the postprandial period using this pH sensor catheter. In addition, we sought to determine postprandial changes of the gastric acid pocket following administration of vonoprazan as compared to rabeprazole, a conventional proton pump inhibitor (PPI), with our system.

MAỤERIALS AND METHODS
Twelve healthy adult volunteers were recruited (7 males, 5 females; mean age 24.0 士 2.6 years). Our novel pH sensor catheter is equipped with 8 vertically awayed pH sensors and was developed in cooperation with Star Medical, Inc. (Tokyo, Japan). Eight-channel pH data can be simultaneously recorded by connecting the catheter to 4 portable digital recorders (Pocket Monitor GMMS-200pH; Star Medical). For the present study, a catheter was inserted transnasally and positioned under X-ray guidance, then postprandial acid pocket formation was monitored over time with the subject in a sitting position.

The enrolled subjects participated in 2 study sessions. In the first session, postprandial gastric acid pocket formation and the effects of vonoprazan at 20 mg on that were assessed. In the second session, the effects of rabeprazole at 20 mg on the acid pocket were assessed. PPIs are known to be slow to achieve steady-state inhibition of gastric acid secretion, typically requiring 2 to 3 days to reach a therapeutic range, thus rabeprazole was administered for 2 days prior to performing pH measurements. A washout period of at least 2 weeks between the study sessions was used.

Recorded data were analyzed using computer software (Eight Star; Star Medical). An acid pocket was defined as the distinct region just below the esophago-gastric junction in the proximal stomach, which is clearly more acidic (pH <4) than other parts of the esophagus and stomach. To assess its characteristics, length, appearance time, lasting time, and mean pH of the most acidic channel were evaluated in each subject. In addition, the separate effects of vonoprazan and rabeprazole on acid pocket formation were assessed.

The study protocol was approved by the Ethics Committee of Shimane University Faculty of Medicine and written informed consent was obtained kom each of the subjects.

RESULTS AND DISCUSSION
All subjects completed the first study session, though the acid pocket was not appropriately measured in 2 due to catheter position, thus they were excluded. The remaining 10 subjects proceeded to the second study session and all completed the testing.

In the first study session, length, appearance time, lasting time, and mean pH for post-prandial acid pockets were assessed. An acid pocket was observed in all 10 analyzed cases and were appropriately measured, with a mean length of 2.2 ± 0.4 channels. The mean appearance time of an acid pocket after completion of a meal was 19.4 ± 6.8 minutes, while mean lasting time was 145.5 ± 17.9 minutes and mean pH was 2.4 ± 0.4.

Next, the effects of vonoprazan on postprandial gastric acid pocket development were evaluated. Following that administration, the acid pocket was completely eliminated in all cases. The mean onset time for apparent acid inhibition by vonoprazan was 133.9 ± 34.2 minutes. In addition, the mean pH after administration was 7.6 士 0.4, which was neutralized within 3 hours in each case. The effects of rabeprazole on postprandial gastric acid pocket formation were also evaluated. Similar to treatment with vonoprazan, the acid pocket was eliminated in 7 of the 10 analyzed subjects. In the 3 with a remaining postprandial acid pocket, the length was reduced and mean pH was greater as compared to before administration. These results suggested that acid pockets examined in the present subjects had a higher incidence of elimination with vonoprazan as compared to rabeprazole, though there was no significant difference between those drugs (p=0.11).

In the present study, formation of a gastric acid pocket in healthy Japanese adults was revealed using our novel 8-channel pH sensor catheter. Results regarding appearance time, length, and mean pH of the pocket were consistent with another investigation conducted in Asia. Previous studies have also perfoRMed gastric acid pocket measurements using a pull-through method with a dual sensor catheter, though difificulties with observing changes over time were noted. As compared with a pull-through technique, visualization of acid pocket changes that occu汀ed during the examination period was easily obtained with the present system by viewing color surface contour plots with a pH-metry.

This is the first known report to present findings regarding the effects of vonoprazan on gastric acid pockets. This drug has been consistently found to provide quicker and stronger acid inhibition than PPis, while the present results indicate that the postprandial acid pocket was completely eliminated and gastric pH neutralized within 3 hours after a single administration of a standard dose (20 mg). In contrast, in 3 of the 10 subjects who received rabeprazole, the acid pocket remained observable for three days after that administration. Consistent with our results, another recent report demonstrated that on-demand therapy using vonoprazan (20 mg) was an effective alternative maintenance therapy for mild reflux esophagitis. An acid pocket is now recognized as an important source of postprandial acid in GERD cases and thus represents a unique therapeutic target. Accordingly,. on-demand therapy with vonoprazan may provide effective treatment for GERD symptoms during the postprandial period.

CONCLUSION
We successhlly examined postprandial gastric acid pocket formation in healthy adults in Japan using our novel vertically arrayed 8-channel pH sensor catheter. Acid pocket development was strikingly suppressed following administration of either vonoprazan or rabeprazole. Moreover, a single administration of vonoprazan completely eliminated the acid pocket in each examined subject within a short period of time, suggesting the effectiveness of that drug as treatment for GERD.

参考文献

1. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut 2018;67:1351-1362.

2. Iwakiri K, Kinoshita Y, Habu Y, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol 2016;51:751-767.

3. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol 2009;44:518-534.

4. Kamada T, Haruma K, Ito M, et al. Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan. Helicobacter 2015;20:192-198.

5. Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Heli- cobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 1997;41:452-458.

6. Iwakiri K, Kawami N, Sano H, et al. Mechanisms of excessive esopha- geal acid exposure in patients with reflux esophagitis. Dig Dis Sci 2009;54:1686-1692.

7. Mittal RK, McCallum RW. Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology 1988;95:593-599.

8. Herbella FA, Vicentine FP, Silva LC, Patti MG. Postprandial proximal gastric acid pocket and gastroesophageal reflux disease. Dis Esophagus 2012;25:652-655.

9. Fletcher J, Wirz A, Young J, Vallance R, McColl KE. Unbuffered high- ly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001;121:775-783.

10. Mitchell DR, Derakhshan MH, Robertson EV, McColl KE. The role of the acid pocket in gastroesophageal reflux disease. J Clin Gastroenterol 2016;50:111-119.

11. Kahrilas PJ, McColl K, Fox M, et al. The acid pocket: a target for treat- ment in reflux disease? Am J Gastroenterol 2013;108:1058-1064.

12. Rohof WO, Bennink RJ, Boeckxstaens GE. Proton pump inhibitors reduce the size and acidity of the acid pocket in the stomach. Clin Gastro- enterol Hepatol 2014;12:1101-1107, e1.

13. Vo L, Simonian HP, Doma S, Fisher RS, Parkman HP. The effect of rabeprazole on regional gastric acidity and the postprandial cardia/gastro- oesophageal junction acid layer in normal subjects: a randomized, double- blind, placebo-controlled study. Aliment Pharmacol Ther 2005;21:1321- 1330.

14. Kinoshita Y, Ishimura N, Ishihara S. Management of GERD: are potassium-competitive acid blockers superior to proton pump inhibitors? Am J Gastroenterol 2018;113:1417-1419.

15. Otake K, Sakurai Y, Nishida H, et al. Characteristics of the novel potas- sium-competitive acid blocker vonoprazan fumarate (TAK-438). Adv Ther 2016;33:1140-1157.

16. Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonopra- zan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects--a randomised open-label cross-over study. Aliment Pharmacol Ther 2015;42:719-730.

17. Boecxstaens V, Bisschops R, Blondeau K, et al. Modulation of the post- prandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. Aliment Pharmacol Ther 2011;33:1370-1377.

18. Wu J, Liu D, Feng C, et al. The characteristics of postprandial proximal gastric acid pocket in gastroesophageal reflux disease. Med Sci Monit 2018;24:170-176.

19. Hila A, Bouali H, Xue S, Knuff D, Castell DO. Postprandial stomach contents have multiple acid layers. J Clin Gastroenterol 2006;40:612-617.

20. Moonen A, Aguilera-Lizarraga J, Bisschops R, Moonen P, Tack J, Boeckxstaens GE. 24-hour multi-pH recording of the postprandial acid pocket and the nocturnal acid distribution at the esophagogastric junction in healthy volunteers. Neurogastroenterol Motil 2019;31:e13694.

21. Beaumont H, Bennink RJ, de Jong J, Boeckxstaens GE. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 2010;59:441-451.

22. Clarke AT, Wirz AA, Seenan JP, Manning JJ, Gillen D, McColl KE. Paradox of gastric cardia: it becomes more acidic following meals while the rest of stomach becomes less acidic. Gut 2009;58:904-909.

23. Ohara S, Furuta K, Adachi K, et al. Radially asymmetric gastroesopha- geal acid reflux in the distal esophagus: examinations with novel pH sen- sor catheter equipped with 8 pH sensors. J Gastroenterol 2012;47:1221- 1227.

24. Fukuda N, Ishimura N, Okada M, et al. Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitis. Endosc Int Open 2017;5:E214-E221.

25. Katsube T, Adachi K, Furuta K, et al. Difference in localization of esophageal mucosal breaks among grades of esophagitis. J Gastroenterol Hepatol 2006;21:1656-1659.

26. Mitchell DR, Derakhshan MH, Wirz AA, et al. The gastric acid pocket is attenuated in H. pylori infected subjects. Gut 2017;66:1555-1562.

27. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helico- bacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:737.

28. Ishimura N, Owada Y, Aimi M, et al. No increase in gastric acid se- cretion in healthy Japanese over the past two decades. J Gastroenterol 2015;50:844-852.

29. Iijima K, Koike T, Abe Y, Ohara S, Nakaya N, Shimosegawa T. Time series analysis of gastric acid secretion over a 20-year period in normal Japanese men. J Gastroenterol 2015;50:853-861.

30. Clarke AT, Wirz AA, Manning JJ, Ballantyne SA, Alcorn DJ, McColl KE. Severe reflux disease is associated with an enlarged unbuffered proxi- mal gastric acid pocket. Gut 2008;57:292-297.

31. Yadlapati R, Vaezi MF, Vela MF, et al. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: rec- ommendations from an expert panel. Am J Gastroenterol 2018;113:980- 986.

32. Oshima T, Arai E, Taki M, et al. Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with ero- sive oesophagitis. Aliment Pharmacol Ther 2019;49:140-146.

33. Vaezi MF, Yang YX, Howden CW. Complications of proton pump in- hibitor therapy. Gastroenterology 2017;153:35-48.

34. Umezawa M, Kawami N, Hoshino S, et al. Efficacy of on-demand therapy using 20-mg vonoprazan for mild reflux esophagitis. Digestion 2018;97:309-315.

参考文献をもっと見る